News
Hearing loss strongly tied to increased dementia risk
“Every 10-decibel increase in hearing loss was associated with 16% greater prevalence of dementia.”
News
Hearing loss strongly tied to increased dementia risk
Even mild hearing loss was associated with increased dementia risk.
News
Modified Atkins diet beneficial in drug-resistant epilepsy
Both adults and adolescents reported benefits from the diet, which is a less strict version of a traditional ketogenic diet.
News
Stem cell transplant superior to DMTs for secondary progressive MS
More than 60% of patients with SPMS who received AHSCT were free from disability progression at 5 years.
News
Prodromal Parkinson’s disease tied to significant functional impairment
Investigators suggest that prodromal Parkinson’s disease should be recognized as a distinct disease stage.
News
Cluster headache tied to high risk of mental and neurologic disorders
Although cluster headaches are often more prevalent in men, researchers found that multimorbidity rates were significantly higher in women.
News
Annual U.S. Parkinson’s disease incidence 50% higher than earlier estimates
About 60,000-90,000 individuals older than 45 years are estimated to be diagnosed with Parkinson’s disease each year.
News
New framework for MS diagnosis and treatment proposed
The new framework is based on underlying biology of disease and acknowledges the different trajectories of individual patients.
News
Traffic-related pollutant tied to increased dementia risk
The clear link between fine particulate matter exposure and increased risk emphasizes the need to address air pollution as a modifiable risk...
News
Can MS be stopped early in its tracks?
Dimethyl fumarate reduced the risk of a first acute or progressive event related to CNS demyelination by more than 80%, compared with placebo.
News
‘Reassuring data’ for two MS meds in pregnancy
Preterm birth, spontaneous abortions, and major congenital anomalies were rare with anti-CD20 drugs ocrelizumab or natalizumab.
News
Viagra, Cialis, and Alzheimer’s risk: New data
“The evidence for the use of the drug was never sufficient for clinicians to use it in their patients.”
News
Stem cell transplantation ‘substantially’ superior to fingolimod in cutting MS relapse risk
AHSCT is substantially superior to fingolimod and marginally superior to natalizumab in reducing the risk of posttreatment relapses.
News
Self-worth training boosts ketamine’s effects in severe depression
The double-blind, randomized clinical trial is the first to assess combining ketamine with a low-cost protective learning program.
News
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
Newborn screening, updated treatment guidelines, and treatment algorithms have changed what can be clinically done for patients with SMA, but...